Amedisys (NASDAQ:AMED) edged lower by 1.2% after a judge tentatively set a date for the Dep. of Justice's challenge of ...
Empowered Funds LLC bought a new stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) during the fourth quarter, Holdings ...
UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
A trial between the Justice Department and UnitedHealth Group Inc. over its proposed purchase of Amedisys Inc. will take place in October 2025, a Maryland federal judge ruled Thursday.
UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...
The healthcare industry is poised for significant growth owing to increased operational efficiency with the addition of ...
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. BATON ROUGE, La., ...
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have been given a consensus rating of “Hold” by the six research firms that are presently covering the company, Ratings reports. Five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback